Pharmacopeia
Master Compare
Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.
| Field |
FRUSEMIDE
Renal · Renal · Level 1
|
HYDROCHLOROTHIAZIDE
Renal · Renal · Level 3
|
|---|---|---|
| Mechanism of action | Diuresis |
inhibit Na+ reabsorption in the early portion of the distal tubule by |
| Physiological effects | Pulmonary and systemic vasodilation |
Anti-HTN: (↓TPR, ↓plasma volume) |
| Absorption | PO/IV/SL/IM. PO BA 50% Onset PO/SL 30-60mins, IV 5 mins . |
PO- BA ~50-80%. Onset 2hrs Dur 6-12hrs. |
| Protein binding | 91-99% (Albumin) |
68% |
| Volume of distribution | 0.1L/kg |
3.6-7.8L/kg |
| Metabolism | Renal to glucuronide |
Not metabolized |
| Excretion | 80% unchanged in urine |
Urine (unchanged) |
| Half-life | 0.5-2hrs. ESRF: 9hrs |
5.6-14.8hrs |
| Adverse Effects Toxicity | ↓ K+/Na+/Cl-/Ca++, Hyper- urea/glu/chol, Metabolic alkalosis |
↓K+/Na+/Mg++, ↑Ca++/urea/glu/chol. |
| Class Group | Diuretic - Loop |
Diuretic - Thiazide |
| Indications Uses | Oedema of cardiac, renal or hepatic origin, Renal insufficency |
heart failure and hypertension. Used in combination. mostly bound to plasma prot, and gain access to the tubule via secretion in the PCT. |
| Introduction | Sulfonamide derivative |
related to the sulphonamides |
| Legacy Cicm Level | Level 1 |
Level 3 |
| Presentation | Photosensitive solution 10mg/ml |
orange scored tablets of 25mg and combos |
| Route And Dose | 20-2000mg daily |
PO. 12.5-200mg/day |